公司资料
MorphoSys 股价、新闻与催化剂
- 股票代码:
- MOR
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Germany and listed in the U
股价为何变动
Current closing-price context is not available for MOR.
公司概览
业务概览
MorphoSys was a German antibody biotechnology company focused on oncology and immunology before its acquisition by Novartis. Its legacy value came from antibody discovery and partnered programs.
所在地与行业分类
Headquartered in Germany and listed in the U.S. as an ADR before acquisition, MorphoSys was a global antibody-biotech name.
商业模式特征
The business relied on partnered assets, royalties, and internal oncology development rather than a broad commercial base.
生物医药行业定位
MorphoSys was a premium antibody platform name and now belongs to biotech M&A history.
未来催化剂
- MorphoSys is now mostly a closeout story, so the catalysts are any remaining value-realization or legacy-asset update rather than a fresh pipeline milestone. The market is focused on what residual value is left.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。